Search results
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Zacks via Yahoo Finance UK· 6 days agoThe CRL was based on observations made after the inspection of a third-party manufacturing facility....
Over 600 B.C. residents have gone to U.S. for cancer care
CBC via Yahoo News UK· 6 days agoRichard Mearow had already had his share of hardships before he was diagnosed with prostate cancer...
Tackling Hard-To-Treat Tumors
Forbes· 1 day agoOne of the ways researchers are trying to address this problem is by disarming the tumor’s defenses against the immune system. This article describes one such effort: a novel antibody that could ...
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
Zacks via Yahoo Finance UK· 2 days agoMerck (MRK) exercises the option that will convert the collaboration deal with partner Orion for...
Sanofi eyes €1.3 billion investment in insulin drug plant in Germany
EuroNews· 2 days agoAlthough Sanofi has not provided much information on this investment, it would be a boost for a...
US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug
Reuters· 7 days ago, opens new tab lung cancer treatment, which belongs to a lucrative class of cancer therapies that work like "guided missiles". The FDA cited findings from ...
IceCure Medical (ICCM) New Cryoablation System Gets FDA Nod
Zacks via Yahoo Finance UK· 17 hours agoIceCure Medical's (ICCM) XSense Cryoablation System receives FDA approval, marking a pivotal step in...
What's Going On With Merck Stock On Monday?
Benzinga via Yahoo Finance UK· 3 days agoOn Monday, Merck & Co Inc (NYSE:MRK) announced the notice of the mutual exercise of an option to convert the companies’ ongoing co-development and...
Natera (NTRA) Soared After a 43% Increase In Revenue
Insider Monkey via Yahoo Finance UK· 20 hours agoArtisan Partners, an investment management company, released its “Artisan Global Equity Fund” first quarter 2024 investor letter. A copy of the letter...
Questor: This ‘wonder drug’ firm is being backed by top fund managers
Daily Telegraph· 4 days agoKeytruda has wildly surpassed expectations, rapidly becoming the world’s top-selling prescription...
